Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04913714 · ClinicalTrials.gov registry record · NA
10+10+30 Infant Vaccines Communication Via Radio in Ethiopia
A NA study of Infant ALL, sponsored by Syracuse University.
- Completed
- Registry status
- NA
- Development phase
- 1,320
- Enrollment target
- 2
- Study locations
NCT04913714: Completed NA study of Infant ALL, sponsored by Syracuse University.
NCT04913714 is a NA study of Infant ALL that has completed, run by Syracuse University. The registered enrollment target is 1,320 participants, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target. The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04913714, a NA study of Infant ALL, has completed, sponsored by Syracuse University.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,320 participants
- Enrollment target
- 2
- Study locations
Study Summary
A cohort study to investigate the effectiveness of radio intervention comprising 10-minute of drama, 10-minute of discussion led by community extension workers, and 30-minute phone-in from listeners on childhood vaccination coverage and timeliness
Primary Outcome
Infant's vaccination record or mother's recall based on interviewer-administered questionnaire
Conditions Studied
Interventions
- BEHAVIORAL 3-month radio intervention on infant vaccination
Study Locations (2)
New York
- Syracuse University - Syracuse
Other
- Jimma University - Jimma
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,320 participants |
| Start Date | 2020-10-13 |
| Est. Completion | 2021-01-31 |
| Phase | NA |
What the finished NCT04913714 record still lists
NCT04913714 is an interventional study that assigns participants to a tested intervention. Its 1,320 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target.
The record links to 1 condition, with Infant ALL appearing as the primary indexed condition, and to 1 intervention - of which 3-month radio intervention on infant vaccination is the first listed.
NCT04913714 reports a single indexed study location in New York, Other.
Frequently Asked Questions
What is clinical trial NCT04913714 about?
NCT04913714 is a clinical study titled "10+10+30 Infant Vaccines Communication Via Radio in Ethiopia". A cohort study to investigate the effectiveness of radio intervention comprising 10-minute of drama, 10-minute of discussion led by community extension workers, and 30-minute phone-in from listeners on childhood vaccination coverage and timeliness
What is the current status of trial NCT04913714?
This trial is currently completed. It is a NA study. The enrollment target is 1,320 participants. The study started on 2020-10-13. Estimated completion is 2021-01-31.
What conditions does trial NCT04913714 study?
This clinical trial studies the following conditions: Infant ALL.
What interventions are being tested in trial NCT04913714?
The interventions under investigation include: 3-month radio intervention on infant vaccination (BEHAVIORAL).
Who is sponsoring clinical trial NCT04913714?
This trial is sponsored by Syracuse University, which has 31 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04913714 being conducted?
This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Infant ALL
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04913714's enrollment target sits among peer trials
1,320 75th of 2000 higher than 1,926 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06557005 · 1,320 participants · NA
Facilitated Transitions From Postpartum to Primary Care Coordination for People With Chronic Conditions
- NCT07213908 · 1,320 participants · NA
Comparing Two School-Based Sleep Health Interventions To Promote Sleep Quality in Youth
- NCT07144800 · 1,319 participants · NA
Family COMIDA (Consumo de Opciones Más Ideales De Alimentos) (Eating More Ideal Food Options)
- NCT05097287 · 1,324 participants · Phase 4
Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Adult Patients With Uncontrolled Moderate to Severe Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI